Two new trials and a meta-analysis presented at the European Society of Cardiology Congress put the spotlight on the use of beta-blocker therapy after myocardial infarction in patients with preserved ...

A large new study found that beta blockers did not provide clear benefits for heart attack patients whose hearts were still ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical ...

Beta-blockers, long considered a standard treatment after heart attacks, may not benefit most patients and could increase ...

Standard drugs given after a heart attack may not benefit those with preserved heart function — and may lead to more risk in ...

Imagine someone you care about suddenly experiencing chest pain, turning pale, and breathing heavily. These are some of the ...

SAN FRANCISCO —The glucagon-like peptide-1 (GLP-1) agonist liraglutide (Victoza, Novo Nordisk) taken every day preserved postprandial insulin secretion for 1 year after type 1 diabetes diagnosis in ...

The .NET library (formerly called .NET Core) doesn't have built-in functions for classical statistics analyses. But it is possible to implement such functions from scratch. This article presents C# ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine. ...

Please provide your email address to receive an email when new articles are posted on . Greater weight loss at 1 year with tirzepatide improved the odds for sustaining an HbA1c of 6.5% or less at 2 ...

The loss of the identity of insulin-secreting beta cells in the islet of Langerhans, a process also called beta cell dedifferentiation, has been proposed to be a main reason for the development of ...